Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals Revenue

In the year 2024, Phathom Pharmaceuticals had annual revenue of $55.25M with 8,001.47% growth. Phathom Pharmaceuticals had revenue of $29.66M in the quarter ending December 31, 2024, with 4,249.56% growth.

• Revenue (ttm): $55.25M
• Revenue Growth: +8,001.47%
• P/S Ratio: 4.60
• Revenue / Employee: $129,396
• Employees: 427
• Market Cap: 274.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	55.25M	54.57M	8,001.47%
Dec 31, 2023	682.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.